MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Adam Golden
Adam GoldenHogan Lovells

Adam Golden

Partner at Hogan Lovells

Lawyer

New York

Deal Bio

Total Deals10
Valued Deals9
Total Value£ 15.66 B
Avg. Deal Size£ 1.74 B

Market Context

Sort

07 Jan 2018|United States|Biotechnology
Impact Biomedicines
Celgene Corporation

Target: IMPACT BIOMEDICINES

Bidder: CELGENE CORPORATION

2 Service Providers

1 Target | 1 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 811 M

Value

09 Jan 2018|Australia|Biotechnology
Elastagen
Allergan

Target: ELASTAGEN PTY LTD

Bidder: ALLERGAN PLC

1 Service Providers

1 Target

6 Dealmakers

6 Target

£ 70 M

Value

22 Jan 2018|United States|Biotechnology
Juno Therapeutics
Celgene Corporation

Target: JUNO THERAPEUTICS INC

Bidder: CELGENE CORPORATION

9 Service Providers

4 Target | 5 Bidder

60 Dealmakers

22 Target | 38 Bidder

£ 5.86 B

Value

09 Jan 2017|United States|Biotechnology
Dendreon Pharmaceuticals
Sanpower Group Co

Target: DENDREON PHARMACEUTICALS INC

Bidder: SANPOWER GROUP CO LTD

2 Service Providers

1 Bidder | 1 Vendor

33 Dealmakers

32 Bidder | 1 Vendor

£ 667 M

Value

09 Apr 2018|United States|Biotechnology
Avexis
Novartis

Target: AVEXIS INC

Bidder: NOVARTIS AG

12 Service Providers

8 Target | 4 Bidder

60 Dealmakers

47 Target | 13 Bidder

£ 5.28 B

Value

16 Apr 2018|United Kingdom|Pharmaceuticals
Shire Oncology Business
Servier International

Target: SHIRE PLC ONCOLOGY BUSINESS

Bidder: SERVIER INTERNATIONAL

9 Service Providers

3 Bidder | 6 Vendor

10 Dealmakers

1 Bidder | 9 Vendor

£ 1.69 B

Value

27 Sep 2018|China|Biotechnology
Cellular Biomedicine Group
Novartis

Target: CELLULAR BIOMEDICINE GROUP

Bidder: NOVARTIS AG

3 Service Providers

1 Target | 2 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 2 M

Value

01 Apr 2019|United States|Pharmaceuticals
Ifm Tre
Novartis

Target: IFM TRE

Bidder: NOVARTIS AG

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

10 Bidder | 1 Vendor

£ 1.20 B

Value

06 May 2019|United States|Biotechnology
Goldfinch Bio
Gilead Sciences

Target: GOLDFINCH BIO

Bidder: GILEAD SCIENCES

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 83 M

Value

08 Jan 2020|United States|Pharmaceuticals
Onspira Therapeutics
Altavant Sciences

Target: ONSPIRA THERAPEUTICS

Bidder: ALTAVANT SCIENCES

5 Service Providers

3 Target | 2 Bidder

9 Dealmakers

1 Target | 8 Bidder

n/a

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite